By proceeding, you agree to our Terms of Use and Privacy Policy.
Antara Banerjee is a Head Director, Cell Engager Therapies, Oncology Drug Discovery Unit at Takeda based in Tokyo, Tokyo
Talks About #Oncology #DrugDiscovery
Preferred Locations #NorthAmerica
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.